| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |